Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BAND
2526
Bandwidth Inc
BAND
$1.73B
| $2.68M | ﹤0.01% |
185,504
+9,774
| +6% | +$114K |
|
2527
Anika Therapeutics
ANIK
$286M
| $2.68M | ﹤0.01% |
118,157
+4,546
| +4% | +$94.1K |
|
2528
Arhaus
ARHS
$1.38B
| $2.67M | ﹤0.01% |
225,336
+4,038
| +2% | +$38K |
|
2529
iQIYI
IQ
$1.25B
| $2.67M | ﹤0.01% |
547,175
-46,466
| -8% | -$220K |
|
2530
Advantage Solutions
ADV
$417M
| $2.67M | ﹤0.01% |
29,459
+515
| +2% | +$36.6K |
|
|
TSVT
2531
DELISTED
2seventy bio
TSVT
| $2.64M | ﹤0.01% |
619,315
+74,413
| +14% | +$229K |
|
2532
Prime Medicine
PRME
$580M
| $2.62M | ﹤0.01% |
296,188
+3,618
| +1% | +$27.9K |
|
2533
MasterCraft Boat Holdings
MCFT
$601M
| $2.61M | ﹤0.01% |
115,101
-12,871
| -10% | -$276K |
|
2534
Distribution Solutions Group
DSGR
$1.61B
| $2.6M | ﹤0.01% |
82,328
+3,406
| +4% | +$96K |
|
2535
LanzaTech
LNZA
$67.3M
| $2.59M | ﹤0.01% |
5,146
+238
| +5% | +$105K |
|
2536
Unilever
UL
$134B
| $2.58M | ﹤0.01% |
47,228
+1,576
| +3% | +$85K |
|
2537
Biomea Fusion
BMEA
$92.8M
| $2.57M | ﹤0.01% |
176,797
+2,369
| +1% | +$28.8K |
|
2538
Coherus Oncology
CHRS
$179M
| $2.56M | ﹤0.01% |
767,697
+44,325
| +6% | +$119K |
|
|
CRGX
2539
DELISTED
CARGO Therapeutics
CRGX
| $2.56M | ﹤0.01% |
+110,395
| New | +$1.87M |
|
2540
Kodiak Gas Services
KGS
$6.37B
| $2.55M | ﹤0.01% |
127,098
+3,220
| +3% | +$58K |
|
2541
Financial Institutions
FISI
$831M
| $2.55M | ﹤0.01% |
119,602
-1,778
| -1% | -$31.7K |
|
2542
Johnson Outdoors
JOUT
$511M
| $2.55M | ﹤0.01% |
47,655
+38
| +0.1% | +$1.95K |
|
2543
NewtekOne
NEWT
$377M
| $2.54M | ﹤0.01% |
183,702
+1,948
| +1% | +$27.2K |
|
2544
Bank of Marin Bancorp
BMRC
$467M
| $2.53M | ﹤0.01% |
114,872
-3,038
| -3% | -$58.3K |
|
2545
Cullinan Oncology
CGEM
$1.27B
| $2.51M | ﹤0.01% |
246,705
+16,719
| +7% | +$148K |
|
2546
American Well
AMWL
$222M
| $2.5M | ﹤0.01% |
83,843
-13,683
| -14% | -$336K |
|
2547
Summit Therapeutics
SMMT
$11.9B
| $2.49M | ﹤0.01% |
953,846
+13,050
| +1% | +$26.8K |
|
2548
Forrester Research
FORR
$224M
| $2.48M | ﹤0.01% |
92,558
-213
| -0.2% | -$5.55K |
|
2549
Xponential Fitness
XPOF
$211M
| $2.46M | ﹤0.01% |
191,173
-3,282
| -2% | -$44.5K |
|
2550
Lyell Immunopharma
LYEL
$343M
| $2.46M | ﹤0.01% |
63,343
+807
| +1% | +$29.1K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.